CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 40 enrolled
Drug / intervention
DFDBA +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00255970
NCT00255970Phase 3Completed
CompareCT.gov

Regenerative Therapy for Vertical Defects Comparing Demineralized Freeze Dried Bone Allograft (DFDBA) and Regenafil

RTI Surgical·interventional·Posted Nov 21, 2005·Updated Aug 10, 2011

In Brief

A Phase 3 clinical trial evaluating DFDBA and Regenafil for Periodontal Diseases. Completed, enrolled 40 participants across 2 sites.

Detailed Summary

The purpose of this research study was to determine whether treatment with the bone grafting material Regenafil was as effective as the standard treatment using demineralized freeze dried bone allograft (DFDBA). Regenafil is demineralized freeze dried bone in a special gel form.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeriodontal Diseases
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 21, 2005
Enrollment StartJan 1, 2006
Primary CompletionNov 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 20.6 years ago

Interventions

DFDBAother

Demineralized Freeze Dried Allograft bone

Regenafildevice

Demineralized Freeze Dried Bone in a porcine gel carrier